Acasti Pharma Inc. Class A Stock price
Is Acasti Pharma Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Acasti Pharma Inc. Class A Stock Analysis
Analyst Opinions
8 Analysts have issued a Acasti Pharma Inc. Class A forecast:
Analyst Opinions
8 Analysts have issued a Acasti Pharma Inc. Class A forecast:
Don't miss a Thing! We will send you all news about Acasti Pharma Inc. Class A directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Acasti Pharma Inc. Class A Stock News
Company Profile
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.
| Head office | Canada |
| CEO | Mr. Kohli |
| Employees | 6 |
| Founded | 2002 |
| Website | www.gracetx.com |


